J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 86 (2005), 2955-2960; DOI 10.1099/vir.0.81265-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pütz, M. M.
Right arrow Articles by Smith, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pütz, M. M.
Right arrow Articles by Smith, G. L.
Agricola
Right arrow Articles by Pütz, M. M.
Right arrow Articles by Smith, G. L.
© 2005 Society for General Microbiology

Short Communication

Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy

Mike M. Pütz1, Isabella Alberini2, Claire M. Midgley1, Ilaria Manini2, Emanuele Montomoli2 and Geoffrey L. Smith1

1 Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, London W2 1PG, UK
2 Department of Physiopathology, Experimental Medicine and Public Health, University of Siena, Via A. Moro, 53100 Siena, Italy

Correspondence
Geoffrey L. Smith
glsmith{at}imperial.ac.uk

Decades after smallpox was eradicated and vaccination discontinued, the level of residual immunity in today's population is largely unknown. This study describes an epidemiological assessment in Italians of antibodies against the intracellular mature virus (IMV) and extracellular envelope virus (EEV) forms of Vaccinia virus. Serum samples (n=642) were taken in 1993 and 2003 from people between 11 and 102 years old. Most citizens >27 years old were positive for antibodies to IMV and EEV. These antibodies were long-lasting and similar titres were present in citizens between 30 and 100 years old. Serum samples from 1993 and 2003 displayed very similar EEV- and IMV-specific antibody titres. By using these data and demographic considerations, it was predicted that, in 2003, 46 % of the Italian population were positive for both IMV and EEV, 42 % were negative for both and 12 % were positive for one antigen.




This article has been cited by other articles:


Home page
 J. Virol.Home page
L. Jing, D. H. Davies, T. M. Chong, S. Chun, C. L. McClurkan, J. Huang, B. T. Story, D. M. Molina, S. Hirst, P. L. Felgner, et al.
An Extremely Diverse CD4 Response to Vaccinia Virus in Humans Is Revealed by Proteome-Wide T-Cell Profiling
J. Virol., July 15, 2008; 82(14): 7120 - 7134.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
A. D. Garcia, C. A. Meseda, A. E. Mayer, A. Kumar, M. Merchlinsky, and J. P. Weir
Characterization and Use of Mammalian-Expressed Vaccinia Virus Extracellular Membrane Proteins for Quantification of the Humoral Immune Response to Smallpox Vaccines
Clin. Vaccine Immunol., August 1, 2007; 14(8): 1032 - 1044.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
N. Jacobs, R. A.-J. Chen, C. Gubser, P. Najarro, and G. L. Smith
Intradermal immune response after infection with Vaccinia virus.
J. Gen. Virol., May 1, 2006; 87(Pt 5): 1157 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Law, G. C. Carter, K. L. Roberts, M. Hollinshead, and G. L. Smith
From the Cover: Ligand-induced and nonfusogenic dissolution of a viral membrane
PNAS, April 11, 2006; 103(15): 5989 - 5994.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2005 by the Society for General Microbiology.